James S. Hanson - Net Worth and Insider Trading
James S. Hanson Net Worth
The estimated net worth of James S. Hanson is at least $422,022 dollars as of 2024-11-05. James S. Hanson is the General Counsel of G1 Therapeutics Inc and owns about 41,087 shares of G1 Therapeutics Inc (GTHX) stock worth over $293,772. James S. Hanson is also the General Counsel of Fortrea Holdings Inc and owns about 7,500 shares of Fortrea Holdings Inc (FTRE) stock worth over $128,250. Details can be seen in James S. Hanson's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that James S. Hanson has not made any transactions after 2024-06-12 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of James S. Hanson
James S. Hanson Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, James S. Hanson owns 2 companies in total, including G1 Therapeutics Inc (GTHX) , and Fortrea Holdings Inc (FTRE) .
Click here to see the complete history of James S. Hanson’s form 4 insider trades.
Insider Ownership Summary of James S. Hanson
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| GTHX | G1 Therapeutics Inc | 2023-01-05 | General Counsel |
| FTRE | Fortrea Holdings Inc | 2024-06-12 | General Counsel |
James S. Hanson Latest Holdings Summary
James S. Hanson currently owns a total of 2 stocks. Among these stocks, James S. Hanson owns 41,087 shares of G1 Therapeutics Inc (GTHX) as of January 5, 2023, with a value of $293,772 and a weighting of 69.61%. James S. Hanson also owns 7,500 shares of Fortrea Holdings Inc (FTRE) as of June 12, 2024, with a value of $128,250 and a weighting of 30.39%.
Latest Holdings of James S. Hanson
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| GTHX | G1 Therapeutics Inc | 2023-01-05 | 41,087 | 7.15 | 293,772 |
| FTRE | Fortrea Holdings Inc | 2024-06-12 | 7,500 | 17.10 | 128,250 |
Holding Weightings of James S. Hanson
James S. Hanson Form 4 Trading Tracker
According to the SEC Form 4 filings, James S. Hanson has made a total of 3 transactions in G1 Therapeutics Inc (GTHX) over the past 5 years, including 1 buys and 2 sells. The most-recent trade in G1 Therapeutics Inc is the sale of 2,368 shares on January 5, 2023, which brought James S. Hanson around $13,071.
According to the SEC Form 4 filings, James S. Hanson has made a total of 1 transactions in Fortrea Holdings Inc (FTRE) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Fortrea Holdings Inc is the acquisition of 2,000 shares on June 12, 2024, which cost James S. Hanson around $50,600.
Insider Trading History of James S. Hanson
- 1
James S. Hanson Trading Performance
GuruFocus tracks the stock performance after each of James S. Hanson's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by James S. Hanson is -16.16%. GuruFocus also compares James S. Hanson's trading performance to market benchmark return within the same time period. The performance of stocks bought by James S. Hanson within 3 months outperforms 1 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how James S. Hanson's insider trading performs compared to the benchmark.
Performance of James S. Hanson
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -11.08 | | | | | |
| Relative Return to S&P 500(%) | -13.01 | | | | | |
James S. Hanson Ownership Network
Ownership Network List of James S. Hanson
Ownership Network Relation of James S. Hanson
James S. Hanson Owned Company Details
What does G1 Therapeutics Inc do?
Who are the key executives at G1 Therapeutics Inc?
James S. Hanson is the General Counsel of G1 Therapeutics Inc. Other key executives at G1 Therapeutics Inc include Chief Financial Officer John V. Umstead , Chief Commercial Officer Andrew Perry , and Chief Business Officer Mark Avagliano .
G1 Therapeutics Inc (GTHX) Insider Trades Summary
Over the past 18 months, James S. Hanson made no insider transaction in G1 Therapeutics Inc (GTHX). Other recent insider transactions involving G1 Therapeutics Inc (GTHX) include a net sale of 78,166 shares made by Rajesh Malik , a net sale of 92,308 shares made by Bailey John E. (jack) Jr. , and a net sale of 15,968 shares made by John V. Umstead .
In summary, during the past 3 months, insiders sold 0 shares of G1 Therapeutics Inc (GTHX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 295,121 shares of G1 Therapeutics Inc (GTHX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 295,121 shares.
G1 Therapeutics Inc (GTHX)'s detailed insider trading history can be found in Insider Trading Tracker table.
G1 Therapeutics Inc Insider Transactions
James S. Hanson Mailing Address
Above is the net worth, insider trading, and ownership report for James S. Hanson. You might contact James S. Hanson via mailing address: 79 Tw Alexander Drive, 4501 Research Commons, Suite 100, Research Triangle Park Nc 27709.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
